Skip to content

Revogene Carba C 410500

by Meridian Bioscience Inc.

Revogene Carba C 410500 is a multiple antimicrobial resistance nucleic acid IVD (FDA Class II) made by Meridian Bioscience Inc., cleared under FDA 510(k) K190275 on 10 May 2019 and listed in FDA GUDID since 15 Jul 2020 (UDI-DI 00840733102370), active as of 8 Nov 2026.

Active United States. Also listed in GUDID (US).

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 8 Nov 2026

Documents

510(k) K190275

FDA submission, from GUDID

Trust

Unverified

Source GUDID, synced 8 Nov 2026.

Regulatory status

as of registry sync 8 Nov 2026

RegionAuthorizationNumberDateStatus
United StatesGUDID listing Number00840733102370 UDI-DI Date15 Jul 2020ListedStatusListed GUDID: in commercial distribution
United StatesFDA 510(k)SESE from GUDID Substantially Equivalent · Traditional NumberK190275 Date10 May 2019DecidedStatusActive

Official records

From the FDA record

Device description
The revogene Carba assay performed on the revogene instrument is a qualitative in vitro diagnostic test designed for the detection and differentiation of the blaKPC, blaNDM, blaVIM, blaOXA-48-like and blaIMP gene sequences associated with carbapenem-non-susceptible pure colonies of Enterobacteriaceae, Acinetobacter baumannii, or Pseudomonas aeruginosa, when grown on blood agar or MacConkey agar. The revogene Carba C assay is intended as an aid for infection control in the detection of carbapenem-non-susceptible bacteria that colonize patients in healthcare settings.
MRI safety
Labeling does not contain MRI Safety Information
Natural rubber latex
No latex statement on the label
Sterility
Supplied non-sterile

From the GUDID record (AccessGUDID), as read on 8 Nov 2026, as the labeller entered it.

Across registries

2 registries list this device

  • FDA 510(k) K190275 decided 10 May 2019 Active
  • FDA GUDID UDI-DI 00840733102370 listed 15 Jul 2020 Listed

Timeline

2 dated events

  1. Cleared FDA 510(k) K190275
  2. Listed FDA GUDID 00840733102370

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

GUDID

Trade name
Revogene Carba C
Generic name
Multiple antimicrobial resistance nucleic acid IVD, kit, nucleic acid technique (NAT)
Model / Ref / Catalog
410500
Primary DI / UDI-DI
00840733102370
510(k) Number
FDA product code
PMY, OOI
GMDN term
Multiple antimicrobial resistance nucleic acid IVD, kit, nucleic acid technique (NAT)
Device class
Class II
Regulation number
866.1640, 862.2570
GUDID distribution status
In Commercial Distribution

Similar devices

Other devices filed under FDA product code OOI.

Other devices from Meridian Bioscience Inc.

See all devices from Meridian Bioscience Inc. →

Properties

  • Single use
  • Prescription use
  • Convenience kit
  • Lot / batch number
  • Expiration date
Other properties (10, all answered No)